International Journal of Pharma Insight Studies
The International Journal of Pharma Insight Studies (IJPIS) is a premier, open-access, and double-blind peer-reviewed journal dedicated to advancing the frontiers of pharmaceutical and health sciences. Our platform serves as a vital bridge between academic discovery and clinical application, fostering global dialogue on cutting-edge advancements in the pharma sector.
IJPIS is committed to disseminating high-quality, evidence-based research that addresses the evolving challenges of global healthcare. By providing immediate open access to our publications, we ensure that innovative research reaches scientists, clinicians, and policymakers worldwide without barriers, maximizing the impact and visibility of our authors' work.
The journal invites original contributions across a multidisciplinary spectrum, ensuring a holistic approach to pharmaceutical research:
Drug Development: Medicinal Chemistry, Drug Discovery, and Pharmaceutical Biotechnology.
Applied Pharmaceutics: Nanotechnology in Drug Delivery, Biopharmaceutics, and Formulation Technology.
Clinical Excellence: Clinical Pharmacy, Hospital Management, Pharmacovigilance, and Drug Safety.
Specialized Studies: Pharmacogenomics, Personalized Medicine, and Molecular Pharmacology.
Health Policy: Regulatory Affairs, Pharmaceutical Policy, and Pharmacoeconomics.
To uphold the highest standards of scholarly publishing, IJPIS operates under strict international protocols:
Academic Integrity: Full adherence to the COPE (Committee on Publication Ethics) guidelines for transparency and ethical conduct.
Rigorous Quality Control: Every manuscript undergoes a stringent double-blind peer-review process and professional plagiarism screening.
Global Collaboration: We foster a diverse knowledge-sharing forum for professionals across industrial, academic, and clinical